Adverum Biotechnologies, Inc. Insider Trading for April 2015

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Adverum Biotechnologies, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Adverum Biotechnologies, Inc. for April 2015.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 30 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	1,000	2,750	98,000
Apr 30 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	35.67	1,000	35,667	7,000	8 K to 7 K (-12.50 %)
Apr 30 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	1,000	2,750	8,000	7 K to 8 K (+14.29 %)
Apr 29 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	35.61	1,192	42,443	45,505	46.7 K to 45.5 K (-2.55 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	38.62	16,875	651,665	436,181	453.1 K to 436.2 K (-3.72 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	2,000	0	2,000	0 to 2 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Grant	A	0.00	2,000	0	453,056	451.1 K to 453.1 K (+0.44 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Option Exercise	A	39.35	20,000	787,000	20,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Grant	A	0.00	7,000	0	7,000	0 to 7 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Grant	A	0.00	2,000	0	2,000	0 to 2 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	A	39.35	23,000	905,050	23,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Grant	A	0.00	8,000	0	11,320	3.3 K to 11.3 K (+240.96 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	A	39.35	20,000	787,000	20,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	1,000	2,750	99,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Grant	A	0.00	7,000	0	7,000	0 to 7 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.21	1,000	39,211	0	1,000 to 0 (-100.00 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	1,000	2,750	1,000	0 to 1,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Option Exercise	A	39.35	67,000	2,636,450	67,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Grant	A	0.00	23,000	0	308,988	286 K to 309 K (+8.04 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Grant	A	0.00	2,000	0	597,989	596 K to 598 K (+0.34 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Option Exercise	A	39.35	20,000	787,000	20,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Grant	A	0.00	7,000	0	7,000	0 to 7 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Option Exercise	A	39.35	25,000	983,750	25,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Grant	A	0.00	9,000	0	9,000	0 to 9 K
Apr 21 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	40.19	1,192	47,910	46,697	47.9 K to 46.7 K (-2.49 %)
Apr 20 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	42.04	200	8,408	595,989	596.2 K to 596 K (-0.03 %)
Apr 20 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	41.59	24,800	1,031,345	596,189	621 K to 596.2 K (-3.99 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	39.93	4,600	183,663	2,438,176	2.4 M to 2.4 M (-0.19 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	40.69	776	31,579	2,442,776	2.4 M to 2.4 M (-0.03 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	39.94	7,350	293,587	2,443,552	2.5 M to 2.4 M (-0.30 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	39.09	12,274	479,843	2,450,902	2.5 M to 2.5 M (-0.50 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	40.74	24	978	47,889	47.9 K to 47.9 K (-0.05 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	39.85	338	13,468	47,913	48.3 K to 47.9 K (-0.70 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	39.10	830	32,450	48,251	49.1 K to 48.3 K (-1.69 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	1,000	2,750	100,000
Apr 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.45	1,000	39,448	0	1,000 to 0 (-100.00 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	1,000	2,750	1,000	0 to 1,000
Apr 13 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	40.38	200	8,076	451,056	451.3 K to 451.1 K (-0.04 %)
Apr 13 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	39.72	17,050	677,202	451,256	468.3 K to 451.3 K (-3.64 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	32	1,250	11,531	11.6 K to 11.5 K (-0.28 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	968	37,353	11,563	12.5 K to 11.6 K (-7.72 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	32	1,250	11,531	11.6 K to 11.5 K (-0.28 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	968	37,353	11,563	12.5 K to 11.6 K (-7.72 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	32	1,250	11,531	11.6 K to 11.5 K (-0.28 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	968	37,353	11,563	12.5 K to 11.6 K (-7.72 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.94	2,500	99,841	620,989	623.5 K to 621 K (-0.40 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	726	28,358	623,489	624.2 K to 623.5 K (-0.12 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	21,774	840,202	624,215	646 K to 624.2 K (-3.37 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	M	0.19	27,500	5,225	27,500
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Sell	S	39.06	887	34,646	3,320	4.2 K to 3.3 K (-21.08 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Sell	S	38.59	26,613	1,026,926	4,207	30.8 K to 4.2 K (-86.35 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Buy	M	0.19	27,500	5,225	30,820	3.3 K to 30.8 K (+828.31 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	9,000	24,750	101,000
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.06	292	11,406	0	292 to 0 (-100.00 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	38.59	8,708	336,019	292	9 K to 292 (-96.76 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	9,000	24,750	9,000	0 to 9 K